TERN

Terns Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality4/10
  • Growth↓ 4/10
  • Value↑ 5/10
Terns Pharmaceuticals sales and earnings growth
TERN Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 13.56%
  • FCF Y/Y↓ -3.80%
Terns Pharmaceuticals gross and profit margin trends
TERN Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -54.41%
Terns Pharmaceuticals net debt vs free cash flow
TERN Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Terns Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗